SCHEMBL29354440

SCHEMBL29354440

c1ccc2c(c1)cnc1cc3ccccc3n12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.39
PBRM1 Q86U86 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CYP1A2 P05177 3/20 0.38
CYP2A6 P11509 1/20 0.38
PDPK1 O15530 1/20 0.38
MAPT P10636 3/20 0.36
RECQL P46063 1/20 0.35
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GPR3 P46089 1/20 0.33
TERT O14746 1/20 0.33
HTR3A P46098 1/20 0.33
DAO P14920 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
KMO O15229 1/20 0.32
GMNN O75496 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4510784 1.00 SMN1; SMN2 (0.39) SMN1; SMN2PBRM1L3MBTL1CYP1A2CYP2A6
SCHEMBL26976529 0.88 MAPT (0.47) MAPT
SCHEMBL29511699 0.82 KDM4E (0.42) SMN1; SMN2PBRM1L3MBTL1CYP1A2CYP2A6
SCHEMBL29511771 0.78 SMN1; SMN2 (0.41) SMN1; SMN2PBRM1L3MBTL1CYP1A2CYP2A6
SCHEMBL29511735 0.78 SMN1; SMN2 (0.34) SMN1; SMN2PBRM1L3MBTL1CYP2A6
SCHEMBL29511741 0.73 THRB (0.39) SMN1; SMN2PBRM1L3MBTL1CYP1A2MAPT
SCHEMBL9601313 0.71 CLK4 (0.36) SMN1; SMN2PBRM1L3MBTL1CYP1A2MAPT
SCHEMBL30649148 0.69 TERT (0.36) SMN1; SMN2PBRM1L3MBTL1CYP1A2MAPT
SCHEMBL29881244 0.69 NPSR1 (0.47) MAPTKMT2AKDM4EADORA3ALDH1A1
SCHEMBL4511748 0.68 ALDH1A1 (0.50) SMN1; SMN2CYP1A2MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112321593-B Preparation method of indolo [1,2-a ] quinazoline-6 (5H) -ketone compound 浙江理工大学 2022-03-18 CN claimed
WO-2024192064-A1 COMPOUNDS AND COMPOSITIONS AS SMARCA2/4 DEGRADERS AND USES THEREOF ONCOPIA THERAPEUTICS, INC. D/B/A/ PROTEOVANT THERAPEUTICS, INC. (US) 2024-09-19 WO disclosed
WO-2024064316-A1 COMPOUNDS AND COMPOSITIONS AS SMARCA2/4 INHIBITORS AND USES THEREOF REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-03-28 WO disclosed
CN-109562111-B CK2 inhibitors, compositions and methods thereof 北极星药业股份有限公司 2023-04-04 CN disclosed
CN-112321593-B Preparation method of indolo [1,2-a ] quinazoline-6 (5H) -ketone compound 浙江理工大学 2022-03-18 CN disclosed
CN-112321593-B Preparation method of indolo [1,2-a ] quinazoline-6 (5H) -ketone compound 浙江理工大学 2022-03-18 CN disclosed
CN-112321593-B Preparation method of indolo [1,2-a ] quinazoline-6 (5H) -ketone compound 浙江理工大学 2022-03-18 CN disclosed